Wird geladen...
Oncolytic virotherapy using herpes simplex virus: how far have we come?
Oncolytic virotherapy exploits the properties of human viruses to naturally cytolysis of cancer cells. The human pathogen herpes simplex virus (HSV) has proven particularly amenable for use in oncolytic virotherapy. The relative safety of HSV coupled with extensive knowledge on how HSV interacts wit...
Gespeichert in:
| Veröffentlicht in: | Oncolytic Virother |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Dove Medical Press
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4918397/ https://ncbi.nlm.nih.gov/pubmed/27512683 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OV.S66086 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|